ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Microsystems, LLC, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Irvine, California.
IPO Year:
Exchange: NASDAQ
Website: clearpointneuro.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/25/2024 | $10.00 | Buy | B. Riley Securities |
| 10/24/2023 | $8.00 | Buy | Stifel |
| 2/16/2023 | $14.00 | Buy | B. Riley Securities |
| 4/5/2022 | $15.00 | Buy | B. Riley Securities |
8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
144 - ClearPoint Neuro, Inc. (0001285550) (Subject)
8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
10-Q - ClearPoint Neuro, Inc. (0001285550) (Filer)
8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
424B5 - ClearPoint Neuro, Inc. (0001285550) (Filer)
8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
DEF 14A - ClearPoint Neuro, Inc. (0001285550) (Filer)
10-K - ClearPoint Neuro, Inc. (0001285550) (Filer)